Talis Biomedical Corporation (TLIS) has a market capitalization of $5.18M and trades at $2.84. The 52-week range is 1.04-2.84.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-34.12, annual revenue of $412K.
The stock has a beta of 1.32, operates in the Healthcare sector.
